303 related articles for article (PubMed ID: 32989677)
1. Immune characteristics distinguish patients with severe disease associated with SARS-CoV-2.
Li X; Liu Y; Li J; Sun L; Yang J; Xu F; Zhou J; Wan L; Xu X; Le A; Zhang W
Immunol Res; 2020 Dec; 68(6):398-404. PubMed ID: 32989677
[TBL] [Abstract][Full Text] [Related]
2. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
3. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.
Liu J; Li S; Liu J; Liang B; Wang X; Wang H; Li W; Tong Q; Yi J; Zhao L; Xiong L; Guo C; Tian J; Luo J; Yao J; Pang R; Shen H; Peng C; Liu T; Zhang Q; Wu J; Xu L; Lu S; Wang B; Weng Z; Han C; Zhu H; Zhou R; Zhou H; Chen X; Ye P; Zhu B; Wang L; Zhou W; He S; He Y; Jie S; Wei P; Zhang J; Lu Y; Wang W; Zhang L; Li L; Zhou F; Wang J; Dittmer U; Lu M; Hu Y; Yang D; Zheng X
EBioMedicine; 2020 May; 55():102763. PubMed ID: 32361250
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of the HNC-LL score for predicting the severity of coronavirus disease 2019.
Xiao LS; Zhang WF; Gong MC; Zhang YP; Chen LY; Zhu HB; Hu CY; Kang P; Liu L; Zhu H
EBioMedicine; 2020 Jul; 57():102880. PubMed ID: 32645614
[TBL] [Abstract][Full Text] [Related]
6. IL-6-based mortality risk model for hospitalized patients with COVID-19.
Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
[TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q
mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-to-Lymphocyte Ratios Are Closely Associated With the Severity and Course of Non-mild COVID-19.
Qun S; Wang Y; Chen J; Huang X; Guo H; Lu Z; Wang J; Zheng C; Ma Y; Zhu Y; Xia D; Wang Y; He H; Wang Y; Fei M; Yin Y; Zheng M; Xu Y; Ge W; Hu F; Zhou J
Front Immunol; 2020; 11():2160. PubMed ID: 32983180
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia.
Zhou Y; Guo S; He Y; Zuo Q; Liu D; Xiao M; Fan J; Li X
Front Cell Infect Microbiol; 2020; 10():322. PubMed ID: 32612961
[No Abstract] [Full Text] [Related]
10. Interleukin-6 and severity of COVID-19 patients in Hefei, China.
Zhao Z; Xie J; Yin M; Yang Y; Ding C; Gao Y; Ma X
Med Mal Infect; 2020 Oct; 50(7):629-631. PubMed ID: 32593746
[TBL] [Abstract][Full Text] [Related]
11. A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.
Yang M; Chen X; Xu Y
Med Sci Monit; 2020 Sep; 26():e926393. PubMed ID: 32914767
[TBL] [Abstract][Full Text] [Related]
12. Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19.
Carissimo G; Xu W; Kwok I; Abdad MY; Chan YH; Fong SW; Puan KJ; Lee CY; Yeo NK; Amrun SN; Chee RS; How W; Chan S; Fan BE; Andiappan AK; Lee B; Rötzschke O; Young BE; Leo YS; Lye DC; Renia L; Ng LG; Larbi A; Ng LF
Nat Commun; 2020 Oct; 11(1):5243. PubMed ID: 33067472
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients.
Haghjooy Javanmard S; Vaseghi G; Manteghinejad A; Nasirian M
J Glob Antimicrob Resist; 2020 Sep; 22():862-863. PubMed ID: 32810639
[TBL] [Abstract][Full Text] [Related]
14. Immune dysfunction following COVID-19, especially in severe patients.
Song CY; Xu J; He JQ; Lu YQ
Sci Rep; 2020 Sep; 10(1):15838. PubMed ID: 32985562
[TBL] [Abstract][Full Text] [Related]
15. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
[TBL] [Abstract][Full Text] [Related]
16. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
[TBL] [Abstract][Full Text] [Related]
17. Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection.
Luo Y; Mao L; Yuan X; Xue Y; Lin Q; Tang G; Song H; Wang F; Sun Z
J Clin Immunol; 2020 Oct; 40(7):960-969. PubMed ID: 32661797
[TBL] [Abstract][Full Text] [Related]
18. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
Akbari H; Tabrizi R; Lankarani KB; Aria H; Vakili S; Asadian F; Noroozi S; Keshavarz P; Faramarz S
Life Sci; 2020 Oct; 258():118167. PubMed ID: 32735885
[TBL] [Abstract][Full Text] [Related]
19. Dynamic profile and clinical implications of hematological parameters in hospitalized patients with coronavirus disease 2019.
Ding X; Yu Y; Lu B; Huo J; Chen M; Kang Y; Lou J; Liu Z
Clin Chem Lab Med; 2020 Jul; 58(8):1365-1371. PubMed ID: 32441666
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and risk factors of patients with severe COVID-19 in Jiangsu province, China: a retrospective multicentre cohort study.
Liu S; Luo H; Wang Y; Cuevas LE; Wang D; Ju S; Yang Y
BMC Infect Dis; 2020 Aug; 20(1):584. PubMed ID: 32762665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
